August 7, 2009 – Using 64-slice CT coronary angiography can avoid further invasive angiographies, which can add up to significant cost savings, according to a new study in the American Journal of Cardiology (August 2009, vol. 104, issue 4, pages 498-500).

Researchers from the Baylor University Medical Center, Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, said in a real world, clinical setting the negative predictive value of low-risk CTA is very high and exceptionally helpful in predicting freedom from events for up to three years. They said 64-slice CT coronary angiography is being used more often in the evaluation of patients with chest pain and the strength of this test is its high specificity and negative predictive value in exclusion of coronary artery disease (CAD).

However, they say its use remains controversial because there are theoretical risks of radiation, additional costs of the test, and no long-term data to suggest that excluding CAD by use of this test results in positive patient outcomes. A total of 436 patients underwent 64-slice CTA because of chest pain thought to be anginal. Cardiac CT was ordered by the primary physician or cardiologist based on a low to intermediate pretest probability of flow-limiting CAD. A smaller subset of patients initially underwent stress testing but had equivocal findings or continued symptoms that warranted further evaluation.

Of the total patient cohort, 376 had no significant CAD based on CTA results. Of the 60 patients who were believed on CTA to have flow-limiting CAD, 34 (57 percent) ended up having percutaneous coronary intervention or coronary artery bypass grafting. The remaining 26 patients (43 percent) did not have true flow-limiting disease on coronary catheterization and were treated medically. With follow-up of 36 months, all patients with minimal or no disease by CTA were free of events or intervention.

For more information: www.ajconline.org


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 27, 2026 — NYC Health + Hospitals/Jacobi | North Central Bronx recently unveiled a new $2 million MRI suite at the ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...

Time February 09, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
Subscribe Now